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Mycobacterium tuberculosis (Mtb) parasitizes host
macrophages and subverts host innate and adaptive
immunity. Several cytokines elicited by Mtb are me-
diators of mycobacterial clearance or are involved
in tuberculosis pathology. Surprisingly, interleukin-
1b (IL-1b), a major proinflammatory cytokine, has
not been implicated in host-Mtb interactions. IL-1b
is activated by processing upon assembly of the in-
flammasome, a specialized inflammatory caspase-
activating protein complex. Here, we show that Mtb
prevents inflammasome activation and IL-1b pro-
cessing. An Mtb gene, zmp1, which encodes a puta-
tive Zn2+ metalloprotease, is required for this pro-
cess. Infection of macrophages with zmp1-deleted
Mtb triggered activation of the inflammasome, result-
ing in increased IL-1b secretion, enhanced matura-
tion of Mtb containing phagosomes, improved
mycobacterial clearance bymacrophages, and lower
bacterial burden in the lungs of aerosol-infected
mice. Thus, we uncovered a previously masked role
for IL-1b in the control of Mtb and a mycobacterial
system that prevents inflammasome and, therefore,
IL-1b activation.
INTRODUCTION
Despite the notoriously high morbidity and mortality associated
with active tuberculosis annually claiming millions of people
worldwide, primary infections with Mycobacterium tuberculosis
(Mtb) are usually controlled in immunocompetent individuals.
The bacterium becomes latent and persists in macrophages
within granulomas but can be reactivated under immunosup-
pressive and other debilitating conditions (Flynn and Chan,
2001). Given these relationships, the already high global burden
of tuberculosis has been further exacerbated by AIDS (Aaron
et al., 2004), making tuberculosis one of the leading causes of
death from an infectious agent in the world (WHO Fact sheet;
http://www.who.in/mediacentre/factsheets/fs104/en/). The role224 Cell Host & Microbe 3, 224–232, April 2008 ª2008 Elsevier Inc.of innate and adaptive immunity in tuberculosis and the associ-
ated cytokine profiles have been studied in great detail (Flynn
and Chan, 2001). Surprisingly, IL-1b has been lacking in such
reports despite being a major proinflammatory cytokine (Dinar-
ello, 1992). The present dearth of information on IL-1b in tubercu-
losis is further underscored by a recent study implicating IL-1
receptor IL-1R1 signaling in antimycobacterial defenses during
acute infection (Fremond et al., 2007).
The generation of active IL-1bs, as well as IL-18 and IL-33,
from their proprotein precursors is a tightly regulated process
dependent on a multiprotein complex referred to as the inflam-
masome (Mariathasan and Monack, 2007; Martinon et al.,
2002; Martinon et al., 2006). There are several well characterized
inflammasomes: the IPAF inflammasome, with IPAF interacting
directly with pro-caspase-1 via its CARD domain, and a number
of NALP-containing inflammasomes, based on the pyrin-domain
containing Nod-like receptors (NLR) NALP-1 and NALP-3, which
require the pyrin- and CARD domain-containing adaptor ASC to
bridge the NLRs to pro-caspase-1 (Kanneganti et al., 2007;
Mariathasan and Monack, 2007; Martinon and Tschopp, 2007;
Suzuki et al., 2007). Caspase-1 is the most extensively studied
of the inflammatory caspases with one of its substrates being
pro-IL-1b, the precursor to IL-1b (Dinarello, 2005a; Ghayur
et al., 1997; Nadiri et al., 2006). Caspase-1 normally exists in
its inactive proform. Various inflammatory triggers, e.g., bacterial
RNA, uric acid crystals, Salmonella flagellin, anthrax lethal toxin,
Staphylococcus aureus, Legionella pneumophilia, Listeria mono-
cytogenes, and Shigella, lead to inflammasome assembly and
hence caspase-1 activation (Cordoba-Rodriguez et al., 2004;
Franchi et al., 2006; Kanneganti et al., 2006; Mariathasan et al.,
2004; Mariathasan et al., 2006; Martinon et al., 2004; Miao
et al., 2006; Molofsky et al., 2006; Ren et al., 2006; Suzuki
et al., 2007). In conjunction with increased pro-IL-1b production
via TLR activation and inflammasome activation, pro-caspase-1
and pro-IL1-b are sequestered into secretory lysosomes, fol-
lowed by Ca2+-dependent exocytosis of active IL-1b (Andrei
et al., 2004; Kahlenberg et al., 2005). Released IL-1b leads to
production of reactive oxygen and nitrogen intermediates and
activation of other proinflammatory cytokines resulting in a vigor-
ous host response to the pathogens and their products (Dinar-
ello, 2005b). Conspicuously, Mtb does not trigger this common
innate defense.
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We have previously proposed that Mtb Zn2+ metalloproteases
(Fratti et al., 2002; Vergne et al., 2003) play a role in intracellular
survival of mycobacteria. We now show that one of the three
corresponding Mtb genes Rv0198c (zmp1), plays a critical role
in preventing caspase-1-dependent activation and secretion of
IL-1b. We demonstrate that the Mtb zmp1 gene is (1) essential
for prevention of inflammasome activation and IL-1b production,
(2) required for mycobacterial survival in macrophages, and (3)
necessary for full virulence in a murine model of tuberculosis.
RESULTS
Generation and Characterization of Mtb zmp1 Mutant
A bioinformatic analysis of Mtb genome revealed three putative
Zn2+ metalloproteases, Rv0198c, Rv1977, and Rv2869c
(Figure 1A), based on the conserved HExxH active site motif
common to all Zn2+ metalloproteases (Figure 1B). A role for
one of the candidate genes Rv2869c has been described in lipid
metabolism (Makinoshima and Glickman, 2005). Since Rv1977 is
deleted in Mycobacterium bovis and, hence, could not be impli-
cated in virulence, we focused our studies on the remaining can-
didate, Rv0198c (zmp1). Phylogenetic analysis of Zmp1 revealed
that it belonged to the M13 family of Zn2+ metalloproteases
implicated in macrophage function, with neprilysin- and endo-
thelin-converting enzyme among its members (Turner et al.,
2001; Wahl et al., 2005). Knockout mutants of zmp1 in Mtb
H37Rv and in M. bovis BCG (Figure 1) were constructed and
confirmed by Southern blots (Figure 1C). We raised polyclonal
antibodies against the 15 aa C-terminal peptide of Zmp1. Mtb
H37Rv extracts revealed a 63 kD band corresponding to Zmp1
that was absent in the zmp1::Kmr mutant (Figure 1D). Although
Zmp1 primary structure revealed no apparent export signal
sequences, Zmp1 was found in culture supernatants (whole-
cell lysates) of zmp1 strain and standard preparations of total
culture filtrate protein found in Mtb culture supernatant
(Figure 1D), indicating that Zmp1 is released from the tubercle
bacilli. Nonspecific lysis was ruled out as a cause of Zmp1 pres-
ence in culture supernatants by probing for a mycobacterial cy-
toplasmic enzyme, KatG, which was not detected in the same
culture supernatant preparations (Figure S1A available online).
Zmp1 Is Required for Mtb Virulence
and Survival in Macrophages
In vitro studies revealed no difference between Mtb H37Rv
zmp1+ (wild-type parental strain), Mtb H37Rv zmp1::Kmr (zmp1
mutant), and Mtb H37Rv zmp1::Kmr(zmp1+) (zmp1+ comple-
mented zmp1 mutant) grown under standard aerated culture
conditions in Middlebrook 7H9 medium (Figure 1E) or between
the BCG zmp1::Kmr, zmp1+ strains grown under static and aer-
ated conditions, indicating that Zmp1 is not essential in axenic
culture (Figure 1F; Figure S1B). However, the zmp1::Kmr mutant
showed reduced growth in mice. C57BL/6 mice were aerosol-
infected with Mtb H37Rv and bacterial burden in the lungs
quantified (Figures 2A and 2B). The zmp1::Kmr mutant strain
was significantly attenuated compared to the zmp1+ parental
strain, which was evident as early as 14 days postinfection
(Figure 2A). The initially established difference was maintained
during a longer course of infection (Figure 2B).
We next examined the zmp1::Kmr mutant strain for survival in
macrophages. M. bovis BCG zmp1+ and zmp1::Kmr strains were
used to infect J774A and RAW264.7 macrophages, and bacterial
viability was quantified as described in the Experimental Proce-
dures. There was a significant reduction in colony counts with
the zmp1::Kmr mutant relative to its zmp1+ parent (Figure 2C),
although mutant uptake by the macrophages was not dimin-
ished (Table S1). These results were confirmed and further
extended by genetic complementation in virulent Mtb H37Rv
using the zmp1+ parental strain, its zmp1::Kmr derivative, and
a zmp1::Kmr(zmp1+) complemented strain (see Figure 1C for
characterization). Inactivation of zmp1 in virulent Mtb resulted
in a 5-fold reduction of viability after 3 days in macrophages.
The loss of viability was fully recovered by complementation
with the wild-type zmp1 gene (Figure 2D). These findings were
Figure 1. Inactivation of Mtb zmp1 Gene
(A) Genetic organization of the three putative Zn2+
metalloprotease-encoding genes in Mtb: zmp1
(Rv0198c), zmp2 (Rv1977; RD15, deleted in
M. bovis), and zmp3 (Rv2869c).
(B) Alignment of the predicted Zmp1 active sites
and neprilysin.
(C) Southern blot analysis: 1, Mtb H37Rv zmp1+
parent; 2, zmp1::Kmr mutant; 3, zmp1::Kmr
(zmp1+) complemented strains.
(D) Western blot analysis: M. bovis BCG zmp1+
and Mtb H37Rv zmp1::Kmr. A, aerated cultures;
S, static cultures; CFP, total culture filtrate protein.
(E) In vitro growth of Mtb H37Rv zmp1+,
zmp1::Kmr, and zmp1::Kmr (zmp1+) in aerated
7H9 cultures.
(F) In vitro growth of M. bovis BCG zmp1+ and
zmp1::Kmr in static 7H9 cultures.
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rophages. Infected human macrophages were incubated for
2 hr, 3 days, and 7 days. Again, a significant reduction in the
viability of Mtb H37Rv zmp1::Kmr mutant relative to its zmp1+
parent was observed (Figure 2D). The results in the animal model
and in murine and human macrophages demonstrate that zmp1
is required for Mtb virulence.
Phagosomes Harboring zmp1 Mutant Mycobacteria
Undergo Maturation into Phagolysosomes
Phagosomes containing the parental zmp1+ strain and
zmp1::Kmr mutant showed differences in their maturation (Fig-
ure 3). RAW264.7 murine macrophages were infected with M.
bovis BCG zmp1+ strain and zmp1::Kmr mutant for 1 hr prior to
processing for confocal microscopy. Transferrin (early endoso-
mal marker) colocalized with 56% zmp1+ bacilli versus 12.5%
zmp1::Kmr bacilli (Figure 3A). Two late endosomal markers
CD63 and LysoTracker DND-99 (LT) colocalized more with the
zmp1::Kmr mutant than with zmp1+ bacilli (Figure 3B and C;
25% versus 68.5% for CD63, and 16% versus 98% for LT).
This was further confirmed via LAMP-1 localization and intrapha-
gosomal pH measurements with Mtb H37Rv wild-type (zmp1+),
mutant (zmp1::Kmr), and complemented (zmp1::Kmr(zmp1+))
strains (Figures S2 and S3). These results indicate that absence
of Zmp1 breaches, directly or indirectly, the mycobacterial
ability to maintain phagosome maturation arrest (Vergne et al.,
2004).
Inhibition of Caspase-1 Reestablishes Arrest
of Phagolysosome Biogenesis and Improves
Survival of the zmp1 Knockout Mutant
To address the mechanism underlying the requirement for zmp1
in mycobacterial virulence, macrophages infected with M. bovis
BCG zmp1+ or zmp1::Kmr mutant strains were treated with
a panel of inhibitors affecting macrophage physiology and
assayed mycobacterial phagosomes for CD63 colocalization.
BAPTA-AM, a Ca2+ chelator used as a positive control, showed
an expected reduction in CD63 colocalization with the
zmp1::Kmr bacilli (Figure S4) in accordance with the known
role of Ca2+ in phagosome maturation (Malik et al., 2000). Of
Figure 2. Zmp1 Is Required for Mtb Virulence
(A) Decreased short-term survival (14 days) of zmp1::Kmr mutant in mice.
C57BL/6 mice were infected via aerosol with 160 CFU of Mtb H37Rv zmp1+
(n = 5 mice) or with 230 CFU of zmp1::Kmr (n = 5 mice). Survival is expressed
as a percent relative to the parent strain.
(B) Extended decrease in bacterial burden with zmp1::Kmr mutant. C57BL/6
mice were infected via aerosol with zmp1+ (filled circles) or with zmp1::Kmr
bacilli (open circles). n = 5 mice (for each time point).
(C) Impaired survival of M. bovis BCG and Mtb H37Rv zmp1::Kmr in macro-
phages. M. bovis BCG parent (zmp1+) and mutant (zmp1::Kmr) or Mtb H37Rv
zmp1+, zmp1::Kmr, and the zmp-complemented strain zmp1::Kmr(zmp1+)
were used, at an moi of 10:1, to infect J774A or RAW264.7 murine macro-
phages. Survival (3 days postinfection) is expressed as % CFU obtained
relative to the zmp1+ strain and was normalized to 0 day (1 to 2 hr postinfection)
counts.
(D) Decreased survival of Mtb H37Rv zmp1::Kmr in primary human monocyte-
derived macrophages. Mtb H37Rv parent (zmp1+) and mutant (zmp1::Kmr)
strains were used to infect human macrophages derived from peripheral blood
monocytes at an moi of 10:1. Survival is expressed as a percent of CFU
obtained relative to the parent strain after 3 and 7 days, normalized to 0 day
(2 hr postinfection). Data represent means ± SEM from three independent
experiments. *p < 0.05; **p < 0.01.
Figure 3. Zmp1 Is Required for Mycobacterial Phagosome Matura-
tion Block
(A) Localization of transferrin relative to M. bovis BCG phagosomes in
RAW264.7 murine macrophages.
(B) Localization of CD63 relative to M. bovis BCG phagosomes.
(C) LysoTracker Red DND-99 staining of M. bovis BCG phagosomes. **p <
0.01 Three independent experiments; n, number of phagosomes counted;
infection time is 1 hr.
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itor (Figure 4A), showed significant reduction in the maturation of
phagosomes harboring the zmp1::Kmr mutant. We next deter-
mined which of the caspases played a role, leading to the iden-
tification of caspase-1 as the caspase responsible for the
increased phagosome maturation of the zmp1::Kmr strain.
Ac-YVAD-cmk (YVAD), a caspase-1 specific inhibitor (Garcia-
Calvo et al., 1998), suppressed the differences between the
zmp1+ and zmp1::Kmr strains. Colocalization of CD63 with
M. bovis BCG zmp1::Kmr in the presence or absence of 50 mM
YVAD revealed a 50% reduction in phagolysosome biogenesis,
similar to that seen with the pan-caspase inhibitor z-VAD (Fig-
ure 4A). These observations were confirmed with Mtb H37Rv
zmp1+ and zmp1::Kmr strains. The zmp1::Kmr mutant showed
enhanced phagolysosome biogenesis, as determined by LT
colocalization, compared to the zmp1+ strain. The increase in
phagosomal maturation observed with the zmp1::Kmr mutant
was abrogated either by genetic complementation with zmp1+
or by addition of YVAD (Figure 4B).
If caspase-1 activation is the mechanism underlying
decreased viability and increased phagosomal maturation of
the zmp1::Kmr mutant, then an addition of exogenous YVAD
should improve its survival in macrophages. Macrophages
were infected with zmp1+ or zmp1::Kmr M. bovis BCG and
treated with YVAD. Figure 4C shows that YVAD restored survival
of the zmp1::Kmr strain. Thus, caspase-1 appears to be activated
by the zmp1::Kmr strain in contrast to the wild-type zmp1+strain.
Activation of caspase-1 was directly tested by comparison of cell
lysates from macrophages infected with M. bovis BCG zmp1+
and zmp1::Kmr, obtained 30 min and 4 hr postinfection. Upon
activation, pro-caspase-1 is cleaved to p20 (active form) and
p10 fragments, with the antibody detecting only the p20 fragment
on immunoblots. For both time points, there was more p20 frag-
ment detected in cell lysates from macrophages infected with
zmp1::Kmr compared to zmp1+ bacteria or to uninfected cells
(Figure 4D; Figure S5). In contrast, caspase-3 (an apoptotic cas-
pase) remained unchanged, indicating that the effect seen with
z-VAD was specific to caspase-1 (Figure S5A).
M. bovis BCG Inhibits Inflammasome Activation
Activation of caspase-1 was also observed when the M. bovis
BCG zmp1+ strain was attenuated by an overnight treatment
with 30 mg/ml chloramphenicol (Figures 5A and 5B). The opposite
was seen with untreated zmp1+ M. bovis BCG: the zmp1+ strain
did not activate caspase-1 processing and was, moreover, capa-
ble of inhibiting inflammasome activation by the prototypical
inflammasome agonists ATP and nigericin (Figures 5A and 5B).
Macrophages from Caspase-1 Knockout Mice
Do Not Display Increased Phagosomal
Maturation of zmp1::Kmr Mutant
The importance ofcaspase-1 in inducingphagosomematurationof
the zmp1::Kmr mutant was assessed in Caspase-1/ bone mar-
row-derived macrophages infected with Mtb H37Rv zmp1+ parent,
Figure 4. Caspase-1 Inhibition Prevents PhagolysosomeBiogenesis
and Improves Survival of the zmp1 Knockout Strain
(A) Caspase-1 inhibition suppresses M. bovis BCG zmp1::Kmr phagosome
maturation. Murine macrophages (J774A) were infected with M. bovis BCG
zmp1::Kmr mutant, incubated with 50 mM z-VAD or 50 mM YVAD for 1 hr,
and processed for confocal microscopy. Three independent experiments; n,
number of phagosomes counted.
(B) Inhibition of caspase-1 with 50 mM YVAD suppresses M. tuberculosis
H37Rv zmp1::Kmr phagosome maturation. Two independent experiments;
n, number of phagosomes; infection time is 1 hr.
(C) Inhibition of caspase-1 rescues M. bovis BCG zmp1::Kmr. Macrophages
were infected with M. bovis BCG zmp1+ and zmp1::Kmr strains, and colonies
were counted after 1 hr and 2 days. Survival is expressed as a percent of CFU
relative to the parent strain (three independent experiments) and normalized to
1 hr time point. Data represent means ± SEM. **p < 0.01; *p < 0.05.
(D) Caspase-1 is activated by M. bovis BCG zmp1::Kmr mutant at 30 min.
GAPDH was used as a loading control. C, control untreated cells.
(E) Densitometric quantification of blot in (D).
Figure 5. M. bovis BCG Inhibits Inflammasome Agonist-Dependent
Activation of Caspase-1
(A) RAW264.7 cells were treated with inflammasome agonists nigericin (20 mM)
or ATP (1 mM), infected with M. bovis BCG for 4 hr where indicated, and
caspase-1 activation assessed by immunoblotting. M. bovis BCG: zmp1+,
wild-type untreated; zmp1++Cm, wild-type attenuated by overnight treatment
with 30 mg/ml chloramphenicol.
(B) Densitometric ratio of active caspase-1 (p20) to b-actin.
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(Figure 6A). When compared to the mutant (zmp1::Kmr) strain in
wild-type macrophages, both the parental (zmp1+) and comple-
mented (zmp1::Kmr(zmp1+)) strains showed lower levels of colocal-
ization with Lysotracker Red as a measure of phagosomal matura-
tion (Figure 6A). The difference in phagosomal maturation between
zmp1 mutant and zmp1+ strains was abrogated when the same
strains were compared in Caspase-1/ macrophages (Figure 6A).
Inflammasome Components Are Important for
Decreased Survival of the zmp1Mutant in Macrophages
Results similar to those obtained with cell biological tracers in
macrophages from caspase-1 knockout mice were seen when
assaying for survival of M. bovis BCG zmp1::Kmr in RAW264.7
cells knocked down for caspase-1 (Figure 6B). In contrast to cas-
pase-1, a knockdown of caspase-3 did not affect killing of
zmp1::Kmr M. bovis BCG (Figure 6B) despite a nearly complete
knockdown of caspase-3 (Figure S6). To determine the type of
inflammasome required for reduced survival of the zmp1mutant,
we knocked down IPAF and ASC, the key components of the
previously characterized inflammasomes (Kanneganti et al.,
2007; Mariathasan and Monack, 2007; Martinon and Tschopp,
2007), and tested survival of M. bovis BCG zmp1+ and
zmp1::Kmr by comparing CFU at 1 hr and 3 days after infection.
The results, displayed in Figure 6B, show that both IPAF and ASC
are important for the killing of the zmp1::Kmr mutant.
Mycobacteria Lacking zmp1 Induce IL-1b
and Superoxide Production in Macrophages
We next tested whether caspase-1 activation upon infection of
macrophages with the zmp1 mutant resulted in IL-1b activation.
Macrophages were infected with M. bovis BCG zmp1::Kmr for
1 hr, treated with neutralizing antibody against IL-1b or with
isotypic IgG control, and assayed for CD63 distribution. The IL-
1b-neutralizing antibody reduced phagosome maturation when
compared to untreated samples or samples with control anti-
body (Figure 7A), showing that IL-1b secreted by zmp1::Kmr-in-
fected macrophages was responsible for the observed increase
in phagolysosome biogenesis. The levels of IL-1b were quanti-
fied directly in cell culture supernatants, when the macrophages
were treated with LPS (250 ng/ml) and ATP (1 mM) as a positive
control for IL-1b induction (Mariathasan et al., 2006) or infected
with zmp1+ or mutant zmp1::Kmr M. bovis BCG for 4 hr. A
Figure 6. Decreased PhagosomeMaturation of zmp1::KmrMutant in
Macrophages from Caspase-1/ Transgenic Mice and Increased
Survival of the zmp1 Mutant Strain upon Knockdown of Inflamma-
some Components
(A) Lysotracker-loaded bone marrow-derived macrophages were infected
with Alexa-488 labeled Mtb H37Rv zmp1+ (wild-type), zmp1::Kmr (mutant),
and zmp1::Kmr(zmp1+) (complemented mutant) strains for 1 hr and proces-
sed for confocal microscopy. Data represent means ± SEM; **p < 0.01;
*p < 0.05; ypR 0.05. n, number of experiments.
(B) Knockdown of inflammasome components rescues killing of M. bovis BCG
zmp1::Kmr. RAW264.7 murine macrophages were transfected for 48 hr with
siRNA (sc sir, scrambled control; Casp-1 si, pro-caspase-1; IL-1b si, pro-IL-
1b; IPAF si, IPAF; casp-3 si, pro-caspase-3), knockdowns were verified by
immunoblotting, and macrophages were infected with M. bovis BCG zmp1+
and zmp1::Kmr strains. Bacterial colonies were counted by plating after 1 hr
and 3 days of infection. Survival is expressed as a percent of CFU at 3 days
time point relative 1 hr uptake. Data represent means ± SEM; **p < 0.01;
*p < 0.05; ypR 0.05. n, number of independent experiments.
Figure 7. IL-1b Induction by Mycobacteria Lacking zmp1 and Its
Effects on Macrophage Function
(A) Neutralizing antibody to IL-1b abrogates increased phagolysosome
biogenesis of zmp1::Kmr mutant mycobacteria. Murine macrophages
(J774A) were infected with M. bovis BCG zmp1::Kmr and treated with 10 mg
neutralizing antibody against IL-1b or control isotypic IgG for 1 hr. Data are rep-
resentative of two independent experiments; n, number of phagosomes.
(B) Increased secretion of IL-1b upon infection with M. bovis BCG zmp1::Kmr.
Murine macrophages (J774) were untreated, treated with 250 ng/ml LPS and 1
mM ATP, or infected with M. bovis BCG zmp1+ or zmp1::Kmr for 4 hr. Super-
natants were assayed for IL-1b. Data are representative of three independent
experiments.
(C) Induction of superoxide generated by M. bovis BCG zmp1::Kmr. J774A
murine macrophages were infected with zmp1+ or zmp1::Kmr M. bovis BCG
for 1 hr in the presence of 150 mg/ml NBT. Dark formazan deposits within phag-
osomes were scored as positive. DPI and Rottlerin were used at 5 mM where
indicated. Data are pooled from three independent experiments and analyzed
using contingency table analysis with Fisher’s exact least square determina-
tion; n, total number of phagosomes examined per condition.
(D) Caspase-1 and IL-1b siRNA knockdowns prevent increased mycobacterial
phagosome maturation associated with zmp1::Kmr mutation. RAW264.7
murine macrophages were transfected overnight with scrambled, caspase-
1, or IL-1b siRNA, and cells were infected and analyzed. *p < 0.05; n, number
of independent experiments; infection time is 1 hr.
(E) Exogenously added IL-1b induces maturation of phagosomes harboring
zmp1+ M. bovis BCG (zmp1+). J774A macrophages were infected with
M. bovis BCG (zmp1+) and treated with recombinant murine IL-1b. Data are
representative of two independent experiments. Data are means ± SEM
(where shown); n, number of phagosomes; *p < 0.05; **p < 0.01.
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macrophages infected with zmp1::Kmr mutant mycobacteria
compared to that of the zmp1+ parental strain (Figure 7B;
250 pg/ml for the zmp1::Kmr mutant versus 25 pg/ml for the
zmp1+ strain). Experiments in vivo revealed elevated levels of
IL-1b in sera from C57BL/6 mice collected 2 weeks postinfection
(Figure S7).
Active caspase-1 cleaves pro-IL-1b yielding a smaller (17 kD)
active IL-1b, but as most of the IL-1b activation occurs during its
exocytosis, the active fragment is not readily visible on immuno-
blots of cellular lysates. Instead, levels of pro-IL-1b, which go up
concomitantly with IL-1b activation (Mariathasan et al., 2006),
can be monitored. At 30 min postinfection, there was no signifi-
cant difference in pro-IL-1b levels. However, there were signifi-
cantly higher levels of pro-IL-1b by 4 hr in zmp1::Kmr-infected
macrophages compared to control and zmp1+-infected macro-
phages (Figure S5B). Pro-IL-1b levels in macrophages infected
with zmp1+ parental bacteria were significantly lower than in
control cells, suggesting that not only did mycobacteria prevent
IL-1b activation but that they also had the ability to downregulate
synthesis of pro-IL-1b (Figure S5B).
We next tested macrophage activation using nitroblue tetrazo-
lium (NBT) in an assay for detection of superoxide. Macrophages
were infected with M. bovis BCG zmp1+ and zmp1::Kmr strains
for 1 hr in the presence of NBT and assayed using confocal
and phase contrast microscopy. There was a significant increase
in superoxide levels accumulated in macrophages infected with
zmp1::Kmr mycobacteria when compared to the zmp1+ bacilli
(Figure 7C). This effect was inhibited by diphenyliodonium
(DPI), an inhibitor of the NADPH oxidase, and Rottlerin, a protein
kinase C inhibitor. DPI also inhibited colocalization of zmp1::Kmr
mycobacteria with CD63 (Figure S4). Macrophage activation in
this process was independent of TNF-a action, as TNF-a levels
in culture supernatants did not differ between the wild-type
and zmp1 mutant strains (Figure S8).
We next examined whether IL-1b knockdown in macrophages
can alter consequences for mycobacteria associated with zmp1
inactivation. The effects of pro-IL1b and pro-caspase-1 siRNA
knockdowns were tested by monitoring both zmp1::Kmr phago-
some maturation (Figure 7D) and mycobacterial survival
(Figure6B). Macrophageswere transfected withscrambled siRNA
control, caspase-1 siRNA, or IL-1b siRNA for 24 hr prior to infec-
tion with mutant zmp1::Kmr M. bovis BCG. Following infection
for 1 hr, CD63 distribution was quantified using confocal micros-
copy. Transfection with caspase-1 or IL-1b siRNA significantly re-
duced phagolysosomal localization of M. bovis BCG zmp1::Kmr
(Figure 7D). A knockdown of IL-1b increased survival of zmp1::Kmr
bacteria to the level seen with the zmp1+ strain (Figure 6B).
Exogenously Added IL-1b Promotes Mycobacterial
Phagosome Maturation
If increased phagolysosome biogenesis and killing of zmp1::Kmr
mutant mycobacteria are a direct result of IL-1b activations, then
addition of exogenous IL-1b should have comparable effects on
zmp1+ mycobacteria. To test this hypothesis, macrophages
were infected with zmp1+ M. bovis BCG and incubated for 1 hr
without or with recombinant IL-1b and assayed for colocalization
of mycobacterial phagosomes with CD63. A dose-dependent
increase in mycobacterial phagolysosome biogenesis wasCseen when compared to untreated controls (Figure 7E), showing
that IL-1b was sufficient to induce mycobacterial phagosome
maturation. Thus, zmp1 was not required in defense against
IL-1b-induced effectors in macrophages, but instead was nec-
essary to preempt IL-1b activation. These results demonstrate
that zmp1 is required by mycobacteria to prevent activation of
the caspase-1/IL-1b inflammasome with critical downstream
consequences for Mtb intracellular survival and virulence.
DISCUSSION
Innate and adaptive cell-mediated immunity plays a major role in
the host response against Mtb (Flynn and Chan, 2001). Among
the cytokines that mediate immunological resistance to tubercu-
losis, TNF-a, IL-12, and IFN-g play essential roles (Altare et al.,
1998; Kamijo et al., 1993; Keane et al., 2001), whereas during
immunological recall response, Th17 cells, producing IL-17, are
important in recruiting Th1 cells to the periphery in the lung
(Khader et al., 2007). Less is known about the early innate
immune response and initial control of Mtb, although the cyto-
kines such as IL-12 and TNF-a can induce early IFN-g production
and appear essential in controlling the disease (Flynn and Chan,
2001). In this work, we have demonstrated that IL-1b, a very early
component of innate immunity responses, is an effective antitu-
berculosis agent when induced or exogenously supplied. Com-
plementary to our findings, a recent report has indicated that
IL-1 receptor may play a role in the control of Mtb (Fremond
et al., 2007). Furthermore, we show here that Mtb inhibits inflam-
masome activation to prevent processing of caspase-1 and
IL-1b. Either a genetic inactivation of the zmp1 gene or a more
general attenuation of the bacilli can bring about inflammasome
and IL-1b activation, normally preempted by the wild-type Mtb.
The present study indicates that a significant aspect of tuber-
cle bacillus pathogenicity is its ability to suppress inflammasome
activation in host macrophages. The process of inhibiting host
cell inflammasome activation depends on the Mtb zmp1 gene.
The inflammasomes activated in the absence of zmp1 depend
on IPAF and ASC. In the simplest rendition of inflammasome
organization, IPAF and ASC belong to different inflammasomes
(Martinon and Tschopp, 2007). For example, only IPAF, but not
ASC, and caspase-1 are implicated in Legionella phagosome
maturation through IPAF-dependent recognition of Legionella
flagellin (Amer et al., 2006). Although IPAF can directly interact
with Caspase-1 via its CARD domain, ASC can homo-oligomer-
ize (Fernandes-Alnemri et al., 2007), and, since it contains both
the pyrin and the CARD domains, it may also participate, as
recently pointed out (Kanneganti et al., 2007; Mariathasan and
Monack, 2007), in linking IPAF with Caspase-1. The above
relationships may underlie both our observations with mycobac-
teria and those by Nun˜ez and colleagues with Shigella (Suzuki
et al., 2007). In the latter case, shigellae, which are like mycobac-
teria nonflagellated microorganisms, induce caspase-1 activa-
tion and IL-1b processing in a process dependent on both
IPAF and ASC (Suzuki et al., 2007). Alternatively to the above
scenario of IPAF and ASC engagement in a common inflamma-
some, a temporal succession of IPAF- and ASC-dependent
inflammasomes may be involved, similar to the time-resolved
relationships implicating both IPAF and ASC inflammasomes in
response to Salmonella (Mariathasan et al., 2004).
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Mycobacterium Blocks Inflammasome-IL-1 ActivationActivation of the caspase-1/IL-1b inflammasome is an impor-
tant first line of defense against microbes (Drenth and van der
Meer, 2006; Martinon et al., 2002; Petrilli et al., 2005; Saleh,
2006; Scott and Saleh, 2007). However, its strong potential in pro-
tection against mycobacteria has hitherto not been recognized,
albeit activation of caspase-1 has been observed for mycobacte-
rial lysates (Netea et al., 2006) and a recent report has indicated
the importance of IL-1R-mediated signaling in tuberculosis immu-
nity (Fremond et al., 2007). Our findings that Mtb blocks inflamma-
some activation underscore the strong but unrealized potential of
IL-1b action against mycobacteria and are in keeping with the
observations that certain pathogenic microorganisms modulate
inflammasome activation in ways best suited to their infectious
cycles. Similar to Mtb, the cowpox virus inhibits inflammasome
activation via a direct block of caspase-1 activation (Johnston
et al., 2005). In contrast, Shigella and Salmonella activate the
inflammasome and utilize the ensuing inflammation for invasion
and disease progression (Lara-Tejero et al., 2006; Monack
et al., 2000; Schroeder and Hilbi, 2007). Based on our work, it is
possible to conclude that Mtb dampens this early host response
by limiting theproductionandactivationof IL-1b.Byusingamyco-
bacterial mutant that is incapable of suppressing IL-1b produc-
tion, we have demonstrated that phagosome maturation block,
intracellular survival of mycobacteria, and full virulence in an
animal model of tuberculosis depend on active suppression of
inflammasome activation by the tubercle bacilli.
The exact details of how the zmp1 gene product acts are not
known. Its predicted sequence indicates that it is a Zn2+ metal-
loprotease. Zn2+ metalloproteases are ubiquitous, found both
in prokaryotes and eukaryotes where they carry out diverse func-
tions. Some, like the matrix metalloproteases, can be as promis-
cuous acting as gelatinases or collagenases. Others have much
stricter specificities and can be highly specialized with very
narrow and unique substrates. Zn2+ metalloproteases from
pathogenic microorganisms include clostridial botulinum and
tetanus toxins that cleave SNAREs and prevent neurotransmitter
exocytosis, anthrax lethal factor that proteolytically inactivates
p38MAPK, and Pseudomonas aeruginosa elastase that
degrades surfactant protein D (Alcorn and Wright, 2004; Lalli
et al., 2003; Park et al., 2002). The putative mycobacterial Zn2+
metalloprotease, Zmp1, possibly when released from Mtb,
may act to prevent the activation of the inflammasome. How-
ever, indirect mechanisms cannot be excluded at present.
Regardless of the details of its action, Zmp1, through this
work, has been identified as an important virulence determinant
and represents a potentially useful drug target. The finding that
IL-1b, when activated, can sway the balance toward Mtb phag-
osome maturation and elimination of the bacilli, represents an
important new insight that should allow development of novel
strategies for prevention of tuberculosis.
EXPERIMENTAL PROCEDURES
Materials
DMEM was from GIBCO; fetal bovine serum (FBS) was from Hyclone; L-gluta-
mine was from Biowhittaker; Histopaque, chloramphenicol, and kanamycin
was from Sigma; and ADC (10% bovine serum albumin fraction V, glucose
and catalase) was from Difco. IL-1b and TNFa ELISA kits and recombinant
mouse IL-1b were from R&D Systems. Anti-CD63 antibody was from Santa
Cruz Biotech, and anti-caspase-1 and anti-caspase-3 antibody were from
230 Cell Host & Microbe 3, 224–232, April 2008 ª2008 Elsevier Inc.Cell Signaling. Neutralizing antibody to IL-1b was from Abcam, and control
rat IgG1 was from Serotec. The Alexa-488 and Alexa-568 secondary
antibodies and lysotracker were from Molecular Probes. Texas Red-labeled
transferrin was from Jackson Immuno Research. The siRNAs were from Dhar-
macon. Diphenyliodonium salt, rottlerin, and nitroblue tetrazolium salt were
from Sigma; z-VAD-fmk and Ac-YVAD-cmk were from Alexis Biochemicals;
and BAPTA-AM was from Calbiochem. C57Bl/6 mice were from Jackson
Laboratory. Mtb culture filtrate protein (CFP) was obtained from J. Beslisle.
Cell and Bacterial Cultures
Mouse macrophage cell lines J774A and RAW 264.7 were maintained in
DMEM, 4 mM L-glutamine, and 10% FBS. Human peripheral blood monocytes
were prepared from normal individual donors by density gradient centrifuga-
tion (4003 g for 30 min) through a Ficoll-Hypaque gradient (Sigma). Adherent
monocytes were matured into macrophages by incubating for 5 days in RPMI
containing 10% human AB serum. Bone marrow macrophages were cultured
from femurs of C57Bl/6 WT and Caspase-1/ mice and maintained in media
containing DMEM, 4 mM L-glutamine, 20% FBS, 30% Macrophage-colony
stimulating factor (L-cell conditioned media). Supernatants from 1-week-old
L-cell cultures were aliquoted and stored at 80C until use. Mtb var. bovis
BCG 1721 wild-type and zmp1::Kmr mutant strains and Mtb H37Rv 1424
wild-type, zmp1::Kmr mutant and zmp1::Kmr(zmp1+)-complemented strains
were grown until midexponential phase in 7H9 broth supplemented with
0.5% Tween 80, 0.2% glycerol, and ADC/OADC at 37C in aerated cultures
(in roller bottles by continuous rotation at 2 rpm) or, when specified, in static
cultures (in roller bottles without rotation) as previously described (Springer
et al., 2001). When appropriate, antibiotics were added at the following
concentrations: kanamycin at 50 mg/ml, streptomycin at 100 mg/ml, and
hygromycin at 50 mg/ml. Mycobacteria either expressed GFP or were fluores-
cently labeled with 5 mg/ml Texas red-X or 0.1 mg/ml Alexa 488 in PBS for 1 hr.
Mtb H37Rv 1424 (Sander et al., 2004), a derivative of Mtb H37Rv (ATCC), or
M. bovis BCG 1721, a derivative of M. bovis BCG Pasteur, carrying a nonre-
strictive rpsL alteration, were used to generate isogenic deletion mutants
deficient in zmp (Rv0198c). For all experiments, mycobacteria were homoge-
nized to remove clumps and opsonized in DMEM supplemented with 10%
FBS for 30 min prior to infection. All manipulations with live Mtb H37Rv were
carried out under Biosafety Level 3 conditions.
Construction of Mtb H37Rv and M. bovis BCG zmp1
Mutants and Generation of Zmp1 Antibody
Mtb Zn2+ metalloprotease gene (zmp = Rv0198c; open reading frame: start,
236.507; stop, 234.519; http://genolist.pasteur.fr/TubercuList) and its flanking
region were isolated from a Mtb BAC clone library (Brosch et al., 1998) and
used to generate allelic replacement mutants as described (Springer et al.,
2001). For complementation, a 4423 bp NotI zmp fragment was cloned into
plasmid pMV361-hyg linearized with HpaI, transformed into Mtb zmp1::Kmr
and selected on hygromycin. Rabbit polyclonal antibody against a C-terminal
15 amino acids peptide of Zmp1 was raised and affinity purified using
commercial sources.
Murine and Macrophage Models of Infection
C57/BL6 mice were infected by aerosolization, and Mtb H37Rv lung bacterial
burden was analyzed as described (Dittrich et al., 2006). Macrophages were
infected with various strains for 1 to 2 hr lysed in cold water, and bacterial col-
ony counts were determined for input, 0 day (1 to 2 hr postinfection), and other
time points indicated as described (Kyei et al., 2006; Roberts et al., 2006).
Knockdowns Using siRNA
RAW 264.7 cells were resuspended in a nucleoporator buffer at a density of
5 3 106 with 1.5 mg of cognate siRNA. Cells were nucleoporated (Amaxa) for
24–48 hr prior to infection.
Confocal Microscopy
Macrophages were prepared for fluorescence microscopy as described (Kyei
et al., 2006; Roberts et al., 2006) and analyzed using an LSM 510 Meta (Zeiss
Inc.).
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IL-1b was from R&D Systems, Inc. 10 mg of rat monoclonal neutralizing Ab
to IL-1b or control rat IgG1 was added at the time of infection and maintained
during the course of infection. Rottlerin and diphenylene iodonium were used
at a final concentration of 5 mM. z-VAD-fmk and Ac-YVAD-CMK were used at
a final concentration of 50 mM. Western blotting was done using antibodies
to caspase-1 and IL-1b (Cell Signaling).
Nitroblue Tetrazolium Assay
Macrophages were infected at an moi of 10:1 with wild-type (zmp1+) or mutant
(zmp1::Kmr) BCG-GFP in the presence of 150 mg/ml NBT. Where indicated,
appropriate inhibitors were added. After 30 min, macrophages were washed
three times in PBS and fixed with 2% paraformaldehyde. Cells were visualized
using phase contrast and confocal microscopy and inspected for characteris-
tic formazan precipitate indicative of superoxide formation.
Western Blot Analysis
BCG lysates were prepared by bead-beating as previously described
(Springer et al., 2001). Uninfected, wild-type, or zmp1::Kmr BCG-infected
macrophages (30 min time point) were lysed for 1 hr in lysis buffer (2% Igepal
CA630, 1:25 complete EDTA-free protease inhibitors, 2 mM PMSF, 2 mM
EDTA, 10 mM Tris, 0.5% Deoxycholic acid, 1 mM sodium orthovanadate,
50 mM sodium fluoride) and solubilized in SDS sample buffer. Samples were
resolved by 12.5% SDS-PAGE and transferred to nitrocellulose. Membranes
were blocked in 5% dry milk in PBS containing 0.1% Tween and probed
with the corresponding secondary Ab (Pierce), and protein was detected via
ECL chemiluminescence (Pierce).
Statistics
Data represented by mean ± SEM were analyzed using Student’s t test. In
some cases, data pooled from three independent experiments were analyzed
using contingency tables with Fisher’s exact least square determination
(Graphpad Prism 4).
Additional Experimental Procedures
Additional Experimental Procedures are given in the Supplemental Data
available online.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, one
supplemental table, and eight supplemental figures and can be found with
this article online at http://www.cellhostandmicrobe.com/cgi/content/full/
3/4/224/DC1/.
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